These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 24500460)

  • 1. Challenges in estimating mortality risk from antipsychotics in people with Alzheimer's disease.
    Carnahan RM
    Am J Psychiatry; 2014 Feb; 171(2):227. PubMed ID: 24500460
    [No Abstract]   [Full Text] [Related]  

  • 2. Psychosis, agitation, and antipsychotic treatment in dementia.
    Devanand DP
    Am J Psychiatry; 2013 Sep; 170(9):957-60. PubMed ID: 24030608
    [No Abstract]   [Full Text] [Related]  

  • 3. Response to Carnahan.
    Lopez OL; Becker JT
    Am J Psychiatry; 2014 Feb; 171(2):227-8. PubMed ID: 24500461
    [No Abstract]   [Full Text] [Related]  

  • 4. The long-term effects of conventional and atypical antipsychotics in patients with probable Alzheimer's disease.
    Lopez OL; Becker JT; Chang YF; Sweet RA; Aizenstein H; Snitz B; Saxton J; McDade E; Kamboh MI; DeKosky ST; Reynolds CF; Klunk WE
    Am J Psychiatry; 2013 Sep; 170(9):1051-8. PubMed ID: 23896958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of antipsychotic prescribing in Belgian nursing homes.
    Azermai M; Elseviers M; Petrovic M; van Bortel L; Stichele RV
    Int Psychogeriatr; 2011 Oct; 23(8):1240-8. PubMed ID: 21418723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Longterm treatment with Risperidone in Alzheimer's disease? No justification for more "drug deaths" in nursing homes!].
    Förstl H
    Dtsch Med Wochenschr; 2013 Jan; 138(1-2):16. PubMed ID: 23250689
    [No Abstract]   [Full Text] [Related]  

  • 7. The modern role of antipsychotics for the treatment of agitation and psychosis in Alzheimer's disease.
    Creese B; Da Silva MV; Johar I; Ballard C
    Expert Rev Neurother; 2018 Jun; 18(6):461-467. PubMed ID: 29764230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of agitation, aggression, and psychosis associated with dementia: a pooled analysis including three randomized, placebo-controlled double-blind trials in nursing home residents treated with risperidone.
    De Deyn PP; Katz IR; Brodaty H; Lyons B; Greenspan A; Burns A
    Clin Neurol Neurosurg; 2005 Oct; 107(6):497-508. PubMed ID: 15922506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discontinuation of risperidone in Alzheimer's disease.
    Ling SM; Bonner AF; McMullen TL
    N Engl J Med; 2013 Jan; 368(2):187. PubMed ID: 23301740
    [No Abstract]   [Full Text] [Related]  

  • 10. Discontinuation of risperidone in Alzheimer's disease.
    Power GA
    N Engl J Med; 2013 Jan; 368(2):186-7. PubMed ID: 23301739
    [No Abstract]   [Full Text] [Related]  

  • 11. Discontinuation of risperidone in Alzheimer's disease.
    Gnjidic D; Hilmer SN
    N Engl J Med; 2013 Jan; 368(2):186. PubMed ID: 23301738
    [No Abstract]   [Full Text] [Related]  

  • 12. Discontinuation of risperidone in Alzheimer's disease.
    Devanand DP; Schultz SK; Sultzer DL
    N Engl J Med; 2013 Jan; 368(2):187-8. PubMed ID: 23301737
    [No Abstract]   [Full Text] [Related]  

  • 13. Psychotropic medications for elders in residential care.
    Croucher M
    N Z Med J; 2008 May; 121(1274):7-9. PubMed ID: 18535640
    [No Abstract]   [Full Text] [Related]  

  • 14. Antipsychotic prescribing to older people living in care homes and the community in England and Wales.
    Shah SM; Carey IM; Harris T; Dewilde S; Cook DG
    Int J Geriatr Psychiatry; 2011 Apr; 26(4):423-34. PubMed ID: 20878663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Agitation and aggressiveness among the elderly population living in nursing or retirement homes in France.
    Léger JM; Moulias R; Robert P; Vellas B; Chapuy PH; Monfort JC; Khoshnood B; Bouee S; Rebah N; Gerard D
    Int Psychogeriatr; 2002 Dec; 14(4):405-16. PubMed ID: 12670061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE): Alzheimer's disease trial.
    Schneider LS; Ismail MS; Dagerman K; Davis S; Olin J; McManus D; Pfeiffer E; Ryan JM; Sultzer DL; Tariot PN
    Schizophr Bull; 2003; 29(1):57-72. PubMed ID: 12908661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antipsychotic treatment of psychosis and agitation in the elderly.
    Daniel DG
    J Clin Psychiatry; 2000; 61 Suppl 14():49-52. PubMed ID: 11154017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. To treat or not to treat? Managing acute symptoms in an elderly patient with Alzheimer's disease.
    Deegan R; Bailey KP
    J Psychosoc Nurs Ment Health Serv; 2001 Oct; 39(10):12-5. PubMed ID: 11697070
    [No Abstract]   [Full Text] [Related]  

  • 19. Psychosis of Alzheimer's disease: clinical characteristics and history.
    Schneider LS; Dagerman KS
    J Psychiatr Res; 2004 Jan; 38(1):105-11. PubMed ID: 14690773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of aripiprazole for psychosis and agitation in dementia.
    Laks J; Miotto R; Marinho V; Engelhardt E
    Int Psychogeriatr; 2006 Jun; 18(2):335-40. PubMed ID: 16255839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.